neurocare AG announces change of legal form, its new Supervisory and Executive board and appoints Dr. Thomas Rudolf to the Executive Board
Bei den "Internationalen Nachrichten" handelt es sich um alle Nachrichten, die auf englisch verfasst und veröffentlicht wurden. Hier sind Nachrichten aller neuroCare Geschäftsbereich zu finden.
October 10 is World Mental Health Day, 2020. We highlight the progress made in mental health therapeutics through the COVID-19 pandemic.
Interview with neuroCare Founder & Executive Chairman Thomas Mechtersheimer
The investment will not only finance the company´s further expansion, including its Japan market entry, but also will safeguard neuroCare’s growth and planned IPO beyond the current COVID-19 crisis.
Visit our virtual stand at OHBM 2020. We look forward to meeting you there - virtually but still in personal contact.
neuroCare Group Founder & Executive Chairman, Thomas Mechtersheimer explains the fundamental role of sleep for people in high performance roles
neuroCare Australia's Dr Trevor Brown contributes to PsychScene Hub with a great article on treatment stratification and personalisation of Neurofeedback using QEEG and neuroCare's leading assessment methods.
Cognitive training, supervised tDCS, neurocoaching and more: Get to know your therapeutic options in times of social distancing.
Kyowa and neuroCare sign an equity participation paving the way for a strategic joint venture in Japan
How to continue therapies online and remotely during a period of reduced direct contact? Learn more about cognitive training and tDCS for home use.
New study identifies Biomarkers in brain activity which predicts response to certain Depression treatments, a breakthrough in Psychiatry and use of EEG assessment technologies in mental healthcare.
A recent cost-utility analysis has found rTMS is not only more cost-effective than Electroconvulsive Therapy, it produces better health outcomes.
Nearly 75% of teen patients seeking treatment for insomnia also suffer from an underlying, diagnosed mental health condition, primarily ADHD or depression, according to a new study.
Article by Kay Sukel, originally published by the Dana Foundation
Meet us at Arab Health 2020
Joint booth of Thuringia/Germany, # Z4B26, hall 4
On 14 - 16 June 2019, Dr. Edith Schneider, Prof. Hartmut Heinrich, Dr. Marion Brickwedde and other speakers gave insights into their work, cases and concepts.
neuroConn plays leading role in research project to develop a new treatment method for people with ADHD.
If you’ve spoken with your doctor about protecting your heart health, you likely received advice about eating well and starting an exercise routine. But a recent study suggests there’s another way to help: get a good night’s sleep.
neuroCare in The Netherlands is pleased to invite the public to their upcoming open house event at the a new location in Eindhoven, Wednesday 6 February 2019.
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene Hub speaks to Dr Martijn Arns, Chief Scientific Adviser, neuroCare Group; Founding Director & Senior Researcher at Research Institute Brainclinics.